Lama Penggunaan Kontrasepsi Depo Medroksi Progesteron Asetat dengan Indeks Massa Tubuh dan Kadar Kolesterol Total

Authors

  • Suratiah Suratiah Poltekkes Kemenkes Denpasar
  • Nengah Runiari Poltekkes Kemenkes Denpasar
  • Dewa Ayu Ketut Surinati Poltekkes Kemenkes Denpasar
  • Ni Nyoman Hartati Poltekkes Kemenkes Denpasar, Indonesia
  • Dewa Made Ruspawan Poltekkes Kemenkes Denpasar

DOI:

https://doi.org/10.33992/jgk.v14i1.1563

Keywords:

Lama pemakaian, DMPA, IMT, Kolesterol

Abstract

BMI and total blood cholesterol levels in Depo Medroxy Progesteron Asetate family planning users in the work area of Puskesmas IV Denpasar Selatan in 2021. This study used a non-probability sampling technique with purposive sampling as many as 32 respondents. Collecting instruments through interviews and measuring Basal Metabolisme Indekx by measuring height and weight and measuring cholesterol levels using the EasyTouch GCU Kit. The results showed that most of the users of injection contraceptive Depo Medroxy Progesteron Asetate were 22 people 68.8% ≥24 months, most of the users of Depo Medroxy Progesteron Asetate injection contraception had a heavy Basal Metabolisme Indekx 40.6%  and cholesterol normal levels 68.8%, rather high cholesterol 25.0% and high cholesterol 6.3%. Hypothesis testing used is the contingency coefficient with a Basal Metabolisme Indekx value of p = 0.001 (p<0.05) and a cholesterol value of p = 0.037 (p<0.05), so there is a relationship between the length of time using Depo Medroxy Progesteron Asetate injection contraceptives and Basal Metabolisme Indekx. and total cholesterol levels in the blood in Depo Medroxy Progesteron Asetate family planning acceptors users in the work area of Puskesmas IV South Denpasar in 2021. Based on the results of the study, it is hoped that this can be taken into consideration in providing education and counseling on how to overcome the side effects that occur, so that family planning acceptors Depo Medroxy Progesteron Asetate contraceptives are the only hormonal contraceptives that consistently have an effect on weight gain which results in changes in BMI and affects the lipid profile resulting in increased cholesterol levels. The purpose of this study was to determine the relationship between the duration of use of DMPA injection contraceptives with can overcome the problem of increasing. weight arising from the use of Depo Medroxy Progesteron Asetate family planning and the importance of measuring cholesterol levels regularly in Depo Medroxy Progesteron Asetate family planning acceptors.

References

Central Intelligence Agency. The World Factbook — Country Comparison: Population. CIA Office of Public Affairs. 2017.

BKKBN. Survei Demografi Dan Kesehatan : Kesehatan Reproduksi Remaja 2017. Badan Kependud dan Kel Berencana Nas. 2017;

Kemenkes RI. Survey Demografi dan Kesehatan Indonesia. Survei Demografi dan Kesehatan Indonesia 2017. 2017.

Kementerian Kesehatan RI Badan Penelitian dan Pengembangan. Hasil Utama Riset Kesehatan Dasar. Kementrian Kesehatan Republik Indonesia. 2018.

Sari F. Studi Komparasi Kadar Glukosa Darah Sewaktu akseptor KB suntik kombinasi dan progestin di Bpm Yosi Trihana Kabupaten Klaten Jawa Tengah. J Kesehat. 2017;8.

Hartanto. Keluarga Berencana dan Kontrasepsi. Jakarta : Sinar Harapan.; 2010.

Dalam T, Ngesti, Herawati, Tutik, Saragih L. Lama Pemakaian Alat Kontrasepsi Hormonal Suntik DMPA dan Gangguan Kardiovaskuler Poltekkes Kemenkes Malang. 2015;

Agustiyanti, Fatimah, Aruben. Hubungan Asupan Makanan Aktivitas Fisik dan Penggunaan Kontrasepsi Hormonal dengan Kadar Kolesterol darah (Studi Pada Wanita Keluarga Nelayan usia 30-40 tahun Di Tambak Lorok Semarang tahun 2017. 2017;

Ratna Novalia Sari. Kontrasepsi Hormonal Suntik Depo Medroxyprogesterone Acetate (DMPA) sebagai Salah Satu Penyebab Kenaikan Berat Badan. 2015;

Downloads

Published

2021-12-25

Issue

Vol. 14 No. 1 (2021): Jurnal Gema Keperawatan

Section

Articles

Citation Check

License

Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License, which permits others to share the work with proper acknowledgment of authorship and initial publication in this journal.

Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work (e.g., posting it to an institutional repository or publishing it in a book), provided that the original publication in this journal is acknowledged.

Authors are also permitted and encouraged to post their work online (e.g., in institutional repositories or on their personal websites) prior to and during the submission process, as it can lead to productive exchanges and earlier and greater citation of published work (see the Open Access Effect).

Most read articles by the same author(s)

1 2 3 > >>